Who Pays for the Next Move? The One Question Behind Six AIM Small-Caps

Every growing small company reaches a moment when the same question is asked of two different owners: whose money pays for the next move? It is a real fork, not a figure of speech. On one side sits the shareholder who already handed over money and now wants it back, or wants it protected. On the other side sits the company's own growth agenda, which announces there is never quite enough. One of them must absorb the cost. In the UK's junior market, the Alternative Investment Market, that choice gets made thousands of times a day, and the share price is usually the receipt.

Six AIM-listed businesses — EMV Capital, Pantheon Resources, MP Evans, Cerillion, Hardide, and Touchstone Exploration — sit at six different points along that single schedule of decisions. Read them together and they are not six stories. They are one story at six stages: which claimant wins, the existing investor or the expansion plan, and what it costs the loser.

Understand that ledger and you can read almost any small-cap. The companies with the nicest narratives are often the ones quietly handing the bill to shareholders. The dullest — a mature business with net cash it refuses to spend on a big story — are often the ones refusing to let growth charge them twice.

The one claiming the prize before it exists: Pantheon

Start with the purest forced choice, and the one with a news hook today. Pantheon Resources holds a 100% working interest in roughly 259,000 acres on Alaska's North Slope, beside the Trans Alaska Pipeline, with certified 2C contingent resources of about 1.6 billion barrels of oil and 6.6 trillion cubic feet of gas. That resource is the prize; the trap is that converting it into cash requires billions of dollars nobody has given it yet.

The company has spent much of 2026 waiting for a farm-in partner — a larger company that would pay to take a share of the acreage in exchange for funding development. It raised $10 million in January to restart testing at its Dubhe-1 well and sharpen seismic at the Kodiak project, and its shares trade near multi-year lows. The farm-out is widely described as the make-or-break catalyst.

Now the two claims. Keep 100% of the prize, and Pantheon must fund a project sized in the billions by selling new shares or borrowing — existing holders absorb the dilution, possibly for years, before any of it pays. Give a partner a stake, and development gets funded, but the claim of the existing shareholder on the 1.6 billion barrels is permanently split. There is no comfortable third option, only a decision about which claim is priced with which discount. Waiting, as the flat 2026 share price shows, is itself a cost: every month of a zero-revenue explorer burns the $10 million raised plus overheads that have already emptied shareholder pockets.

The one that already sent the invoice: Touchstone

Touchstone Exploration shows what the Pantheon version looks like once the bill has actually arrived. The Trinidad producer's full-year results earlier in 2026 carried a going-concern warning, and its balance sheet carries roughly US$76 million of net debt. In June it raised about US$10.9 million through new shares priced at 7 pence — the price of the verdict is written on the placing, not in any press release.

There is a defensible version of that raise: production rose 8% in the first quarter, gas output from the Cascadura field is improving, and the money restocks a drilling programme. But the mechanics matter more than the narrative. A company that must repeatedly sell new shares at whatever price the market will pay is asking the existing holder to finance the recovery on the creditor's terms, not their own. The going-concern flag is the moment the growth claim and the survival claim merged, and the shareholder was told they were the same invoice.

The one crossing, and the one that never left

Hardide is the coating technology firm right at the crossing between the two regimes. Its first-half revenue to March 2026 jumped 71% to £4.8 million, a record first half, and in July the shares jumped 21% to around 90p after the company said full-year revenue was materially ahead of forecasts — a "revenue doubling arrives early" moment. This is the stage where a serial raiser starts to believe it can pay its own way, and the question is whether the new cash stays in the business or starts going back to holders. Watch which one the board chooses; it is the tell of whether the thesis changed.

At the far end of the schedule sit the two businesses that generate their own money and have stopped asking anyone else to pay. Cerillion, the telecom billing software firm, closed its fiscal 2025 with net cash of £34.4 million and raised its dividend 17% to 15.4p, against a record order book — the shareholder's claim is being paid in cash, not promises. MP Evans, the Indonesian palm-oil producer, reported a record 2025 dividend of 60p and is now balancing that payout against a small US$2 million purchase of new planting land. That is the luxury version of the fork: whether growth is cheap enough to buy, or whether returning cash is the better use.

And in the middle stands EMV Capital, a deep-tech venture group that manages £112.5 million of assets and continuously raises its own equity to feed an illiquid portfolio of early-stage companies. It is the only one of the six whose entire business model is the fork: it asks its investors to wait for returns that arrive on someone else's schedule, and it rewards them in fair-value mark-ups rather than cash.

What the schedule teaches

Line the six up and the pattern is not about sectors — software, palm oil, oil, coatings, venture. It is about who funds the next step. Cerillion and MP Evans ask little of their holders and pay them; the market trusts them, which is why their shares do not need a rescue raise. Pantheon, Touchstone, and EMV must fund plans that outrun their cash by selling equity or finding partners; their shares are priced to a perpetual assumption that somebody, usually the existing holder, keeps writing cheques.

The useful habit for anyone sizing up an AIM stock is to ask the ledger question before the thesis question. Who wants the growth — the management, who is rewarded with a bigger company, or the investor, who is rewarded with a dividend or a rising price? If the answer is mainly the first, trace where the money will come from. The business whose growth is self-funded, like Cerillion, is not automatically the best buy; but it is the one where the two claimants are not at war. The business that must dilute, like a Touchstone at 7p, is not automatically a fraud; it is simply a place where the investor's money is the fuel and the tank is empty until someone fills it.

Today, Pantheon and MP Evans both issue interim results, the first mid-story of the most extreme pair on this schedule. MP Evans reports to judge whether a cash machine is still choosing to pay. Pantheon reports to tell investors whether the partner is still coming and at what price — which is to say, whether the existing holder's claim on a billion barrels just got cheaper or just got split. Either way, the invoice is real. The only question is whose name is on it.